Research Progress on Cognitive Deficits in Down Syndrome: Molecular Mechanisms and Therapeutic Strategies

This review examines the molecular basis of cognitive dysfunction in Down syndrome, focusing on the roles of NRIP1 and DYRK1A genes in the pathogenesis. The article synthesizes current research on these genetic mechanisms and discusses emerging therapeutic strategies aimed at preventing and treating cognitive impairment in individuals with Down syndrome.